PT  - JOURNAL ARTICLE
AU  - Johannesen, Katrine M
AU  - Iqbal, Sumaiya
AU  - Guazzi, Milena
AU  - Mohammadi, Nazanin A
AU  - Pérez-Palma, Eduardo
AU  - Schaefer, Elise
AU  - De Saint Martin, Anne
AU  - Abiwarde, Marie Therese
AU  - McTague, Amy
AU  - Pons, Roser
AU  - Piton, Amelie
AU  - Kurian, Manju A
AU  - Ambegaonkar, Gautam
AU  - Firth, Helen
AU  - Sanchis-Juan, Alba
AU  - Deprez, Marie
AU  - Jansen, Katrien
AU  - De Waele, Liesbeth
AU  - Briltra, Eva H
AU  - Verbeek, Nienke E
AU  - van Kempen, Marjan
AU  - Fazeli, Walid
AU  - Striano, Pasquale
AU  - Zara, Federico
AU  - Visser, Gerhard
AU  - Braakman, Hilde M H
AU  - Haeusler, Martin
AU  - Elbracht, Miriam
AU  - Sternman, David
AU  - Vaher, Ulvi
AU  - Smol, Thomas
AU  - Lemke, Johannes R
AU  - Platzer, Konrad
AU  - Kennedy, Joanna
AU  - Klein, Karl Martin
AU  - Billie Au, Ping Yee
AU  - Smyth, Kimberly
AU  - Kaplan, Julie
AU  - Thomas, Morgan
AU  - Dewenter, Malin K
AU  - Dinopoulos, Argirios
AU  - Campbell, Arthur J
AU  - Lal, Dennis
AU  - Lederer, Damien
AU  - Liao, Vivian W Y
AU  - Ahring, Philip K
AU  - Møller, Rikke S.
AU  - Gardella, Elena
TI  - Structural mapping of <em>GABRB3</em> variants reveals genotype-phenotype correlations
AID  - 10.1101/2021.06.04.21256727
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.04.21256727
4099  - http://medrxiv.org/content/early/2021/06/04/2021.06.04.21256727.short
4100  - http://medrxiv.org/content/early/2021/06/04/2021.06.04.21256727.full
AB  - Purpose Pathogenic variants in GABRB3 have been associated with a spectrum of phenotypes from severe developmental disorders and epileptic encephalopathies to milder epilepsy syndromes and mild intellectual disability. In the present study, we analyzed a large cohort of individuals with GABRB3 variants to deepen the phenotypic understanding and investigate genotype-phenotype correlations.Methods Through an international collaboration, we analyzed electro-clinical data of unpublished individuals with variants in GABRB3 and we reviewed previously published cases. All missense variants were mapped onto the 3D structure of the GABRB3 subunit and clinical phenotypes associated with the different key structural domains were investigated.Results We characterize 71 individuals with GABRB3 variants, including 22 novel subjects, expressing a wide spectrum of phenotypes. Interestingly, phenotypes correlated with structural locations of the variants. Generalized epilepsy, with a median age at onset of 10.5 months, and mild-to-moderate intellectual disability were associated with variants in the extracellular domain. Focal epilepsy with early onset (median: 2.75 months of age) and severe intellectual disability were associated with variants in the pore-lining helical transmembrane domain.Conclusion These genotype/phenotype correlations will aid the genetic counseling and treatment of individuals affected by GABRB3-related disorders. Future studies may reveal whether functional differences underlie the phenotypic differences.Key pointsPathogenic variants in GABRB3 cause a wide range of phenotypesMissense variants in the ECD have generalized epilepsy with later onset and non-severe IDMissense variants in the TMD have focal epilepsy with early onset and severe IDBehavioral issues are common features of GABRB3 diseasePrecision medicine approaches for GABRB3 disease is limitedCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Novo Nordisk Foundation (NNF19OC0058749 to RSM), the Agencia Nacional de Investigacion y Desarrollo (ANID, PAI77200124 to EP) of Chile and the FamilieSCN2A foundation 2020 Action Potential Grant (to EP). PS worked within the framework of the DINOGMI Department of Excellence of MIUR 2018-2022 (legge 232 del 2016).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All institutions involved in human participant research received local IRB approval (main IRB: The ethics committee of Region Zealand, Denmark). Written informed consent, including authorization for reproduction of video images, was obtained for all individuals (or legal guardians) and family members where necessary. Individual data were collected according to local ethics committee guidelines.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data will be made available to those eligible. Data includes the GABRB3 database and data used for 3D analysis including statistical logging. Data will be stored for six months.